Date published: 2025-10-25

1-800-457-3801

SCBT Portrait Logo
Seach Input

OR1D5 Inhibitors

OR1D5 inhibitors belong to a class of compounds that specifically target and inhibit the activity of the olfactory receptor 1D5 (OR1D5), which is a G-protein-coupled receptor (GPCR) involved in olfactory signaling. Olfactory receptors like OR1D5 are members of a larger family of receptors responsible for detecting odorant molecules in the environment, translating chemical signals into neural responses. The inhibition of OR1D5 function results in the disruption of specific odorant-receptor interactions, providing insight into the molecular mechanics of olfaction. Structurally, OR1D5 inhibitors can vary widely, with their design often centered around mimicking or blocking the natural ligand that activates OR1D5. By impeding the receptor's ability to bind to its target molecules, these inhibitors modulate receptor activity, leading to altered olfactory signal transduction pathways.

From a chemical perspective, the synthesis and development of OR1D5 inhibitors involve precise understanding of receptor-ligand binding dynamics, including hydrophobic interactions, hydrogen bonding, and spatial complementarity within the receptor's binding pocket. Researchers utilize structure-activity relationship (SAR) studies to determine key molecular features that enhance inhibitory potency, selectivity, and stability. Advanced techniques such as molecular docking and computational modeling play a significant role in designing novel inhibitors, providing theoretical predictions on binding affinity and orientation within the receptor. Additionally, chemical optimization through iterative synthesis and testing helps refine the properties of these compounds, ensuring they effectively target OR1D5 without off-target effects on other olfactory receptors or GPCRs. This focused approach in the chemical characterization of OR1D5 inhibitors enables a deeper understanding of olfactory receptor function and their broader roles in sensory systems.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$76.00
$150.00
$725.00
$1385.00
$2050.00
73
(3)

Activates adenylate cyclase, increasing cAMP levels, which can modulate the activity of various proteins including olfactory receptors like OR1D5.

IBMX

28822-58-4sc-201188
sc-201188B
sc-201188A
200 mg
500 mg
1 g
$159.00
$315.00
$598.00
34
(1)

Non-selective inhibitor of phosphodiesterases, increases intracellular cAMP by preventing its breakdown, indirectly affecting OR1D5 activity.

KT 5720

108068-98-0sc-3538
sc-3538A
sc-3538B
50 µg
100 µg
500 µg
$97.00
$144.00
$648.00
47
(2)

Inhibits protein kinase A (PKA), which is involved in the phosphorylation of proteins downstream of cAMP signaling, affecting OR1D5 indirectly.

H-89 dihydrochloride

130964-39-5sc-3537
sc-3537A
1 mg
10 mg
$92.00
$182.00
71
(2)

Another PKA inhibitor, can decrease the phosphorylation of cellular proteins involved in cyclic nucleotide signaling, thus influencing OR1D5.

ODQ

41443-28-1sc-200325
sc-200325A
10 mg
50 mg
$76.00
$218.00
13
(1)

Inhibits guanylyl cyclase, reducing cGMP levels, which can have various effects on cellular signaling pathways affecting OR1D5.

L-NG-Nitroarginine Methyl Ester (L-NAME)

51298-62-5sc-200333
sc-200333A
sc-200333B
1 g
5 g
25 g
$47.00
$105.00
$322.00
45
(1)

Inhibits nitric oxide synthase, which can affect cGMP levels and therefore indirectly influence signaling pathways involving OR1D5.

Ro 20-1724

29925-17-5sc-200709
sc-200709A
sc-200709B
100 mg
1 g
5 g
$85.00
$418.00
$1543.00
17
(1)

Inhibitor of phosphodiesterase type 4, increases cAMP by preventing its breakdown, potentially modulating OR1D5.

Rp-cAMPS

151837-09-1sc-24010
1 mg
$199.00
37
(1)

cAMP analog that inhibits PKA, can decrease phosphorylation of cellular proteins involved in cAMP signaling, therefore affecting OR1D5.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

Inhibits PI3K, potentially affecting downstream signaling pathways that can influence OR1D5 activity.